Value through Innovation27 July 2016

What is a lay summary?

Lay Summaries and Lay Summary Videos

  • BI 409306 - Schizophrenia
    Clinical Study Number 1289.6
    Study Indication Schizophrenia
    Product BI 409306
    Generic Name BI 409306
    Lab Code BI 409306
    Clinical Phase II
    Study Title

    A phase II randomised, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of four orally administrated doses of BI 409306 during a 12-week treatment period in patients with schizophrenia on stable antipsychotic treatment

    Study Document
    Lay summary 1289.6 english